Open AccessFormyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction
Author(s) -
Martha Lappas,
Sharon A. McCracken,
Kelly J. McKelvey,
Ratana Lim,
Joanna L. James,
Claire T. Roberts,
Thierry Fournier,
Nadia Alfaidy,
Katie Powell,
Anthony J. Borg,
Jonathan Morris,
Bryan Leaw,
Harmeet Singh,
Peter R. Ebeling,
Euan M. Wallace,
Laura J. Parry,
Evdokia Dimitriadis,
Padma Murthi
Publication year - 2017
Publication title -
molecular human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.143
H-Index - 122
eISSN - 1460-2407
pISSN - 1360-9947
DOI - 10.1093/molehr/gax067
Subject(s) - biology , trophoblast , placenta , receptor , peptide , endocrinology , medicine , fetal growth , growth restriction , pregnancy , fetus , genetics , biochemistry
What is the association between placental formyl peptide receptor 2 (FPR2) and trophoblast and endothelial functions in pregnancies affected by foetal growth restriction (FGR)?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom